HoYoverse has officially shed light on the details of the upcoming character and weapon banners that the Phase 2 update will bring to the game. If you’re a fan of Genshin Impact, there’s plenty of new ...

Read on to learn more about the project + what’s next. Broad Metro acquires 121.3 acres for Stadium Trace Village Phase II Broad Metro is kicking off the New Year with a key acquisition for the next ...

Credit: MillaF / Shutterstock. Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics have reported positive topline data from Hengrui’s Phase II obesity trial, considering an 8mg dose of the ...

“With Phase II, we’re creating a new chapter for Hoover, blending healthcare, community amenities, and sustainable development to meet the evolving needs of residents and businesses.” ...

Fresh from a $400 million series A round, Kailera Therapeutics has shown off phase 2 data on an obesity candidate it believes can muscle in on the market. Kailera and partner Jiangsu Hengrui ...

Patient enrollment has been completed ahead of schedule in a Phase 2 clinical trial evaluating Contineum Therapeutics‘ PIPE-307, an oral therapy aiming to restore myelin — a process known as ...

The launch of the Bhopal Metro Phase II is expected by the end of January or early February 2025, as the Madhya Pradesh government eyes the completion of both metro phases before the state ...

The drug missed the primary endpoints of two phase 2 trials, showing no difference from the placebo in the positive and negative syndrome scale total score, an industry measure of schizophrenia ...

MANILA, Philippines — Transportation Secretary Jaime Bautista said the department is nearing a resolution to the right-of-way issue of Phase 2 of the Light Rail Transit Line 1 (LRT 1 ...

The trial will enrol nearly 280 adult subjects with obesity. Credit: Hunterframe / Shutterstock. Viking Therapeutics has announced the start of a Phase II clinical trial for VK2735, an oral tablet ...

13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ...

(NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease has been officially named CALMA (Calming Agitation in ...